Related Experiment Video
Updated: Sep 17, 2025

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
Published on: May 17, 2024
Single pill combination therapy for hypertension: New evidence and new challenges: Combination Therapy for
Martin Rosas-Peralta1, Giuseppe Mancia2, Miguel Camafort3
1GREHTA (Group of Experts in Hypertension). México.
Insights
Hypertension (HTN) management requires careful cardiovascular risk stratification. This study proposes a practical clinical approach to guide pharmacological therapy, emphasizing individualized treatment strategies for better patient outcomes.
Area of Science:
- Cardiology
- Internal Medicine
- Public Health
Background:
- Hypertension (HTN) is a major global risk factor for cardiovascular events and mortality, affecting approximately 30% of adults worldwide.
- Current cardiovascular risk stratification scales have limitations, necessitating practical clinical approaches for effective management.
Purpose of the Study:
- To discuss the challenges in cardiovascular risk stratification for hypertensive patients.
- To propose a practical clinical approach for determining cardiovascular risk and guiding pharmacological therapy.
- To provide recommendations for primary care physicians in managing hypertension.
Main Methods:
- The study reviews existing risk stratification methods and their limitations.
- It outlines a clinical approach based on risk factors, blood pressure elevation, target organ damage, and cardiovascular event history.
- It discusses current dual and potential triple therapy recommendations.
Main Results:
- A practical clinical approach integrating multiple factors is presented as a viable alternative to complex risk scales.
- The need for dual therapy is highlighted, with a recommendation for initiating triple therapy in high-risk patients with severe hypertension.
- The article aims to equip primary care physicians with tools for effective hypertension management.
Conclusions:
- Effective cardiovascular risk stratification is essential for optimizing hypertension treatment.
- A simplified clinical approach can aid primary care physicians in making timely therapeutic decisions.
- Individualized treatment strategies, including potential triple therapy, are crucial for managing high-risk hypertensive patients.
Abstract:
Hypertension (HTN) continues to be one of the most important risk factors for major cardiovascular events and mortality. The global prevalence of hypertension is approximately 30% among adults over 20 years old. Cardiovascular risk stratification is crucial to determine the most appropriate pharmacological therapeutic strategy for hypertensive patients. Despite the many scales to stratify risk, none is perfect and represents weighted mathematical models to determine risk at 10 years. Reports have identified numerous limitations, and the challenge persists. A practical way to determine CV risk is the clinical approach based on 1) the number of risk factors, 2) the degree of elevation of blood pressure, 3) the presence of target organ damage/DM/CKD, and 4) a history of major cardiovascular events. Currently, it is recommended to start with dual therapy in a single pill (either ACE inhibitors or ARB2 + dihydropyridine calcium channel blockers or thiazide/thiazide-like diuretic); however, many patients could need to start with triple therapy (low or standard doses) if they belong to the high- or very high-risk group with elevation grade 2 or 3 of blood pressure. This article discusses this topic and establishes some practical recommendations for the physician of first contact.
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Drug Therapy
Antianxiety Medications
Hypertension III: Clinical Manifestations and Diagnostic Studies
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Atherosclerosis III: Management

